HOUSE_OVERSIGHT_024013.jpg
2.85 MB
Extraction Summary
2
People
5
Organizations
0
Locations
2
Events
2
Relationships
3
Quotes
Document Information
Type:
Investment memorandum / fund prospectus
File Size:
2.85 MB
Summary
This document appears to be page 2 of a confidential investment memorandum or prospectus for 'New Leaf' (NLV) funds, specifically discussing the transition of Jim Niedel to Venture Partner for the NLV-III fund. It highlights the 'Long Term Track Record' of the fund managers, noting they have invested over $1.6 billion since 1995 through NLV and Sprout Capital funds, consistently outperforming benchmarks like Cambridge Associates. The document bears a House Oversight Committee stamp, suggesting it was part of a congressional investigation.
People (2)
| Name | Role | Context |
|---|---|---|
| Jim Niedel | Venture Partner / Senior Member |
MD PhD working with the team for over twelve years; changing status to Venture Partner with the closing of NLV-III.
|
| Fund Managers | Investment Team |
A 6 member senior team with 80+ years of venture investing experience.
|
Organizations (5)
| Name | Type | Context |
|---|---|---|
| New Leaf |
Venture capital team/firm (New Leaf Venture Partners implied).
|
|
| NLV |
Investment entity managing funds NLV-I, NLV-II, and NLV-III.
|
|
| Sprout Capital |
Previous funds (Sprout Funds) whose healthcare technology portfolios are part of the team's track record.
|
|
| Cambridge Associates |
Used as a benchmark for investment returns.
|
|
| House Oversight Committee |
Source of the document (via stamp).
|
Timeline (2 events)
Relationships (2)
Jim Niedel MD PhD has worked with the team continuously for over twelve years
NLV-I, NLV-II and the healthcare technology portfolios in the Sprout Capital funds
Key Quotes (3)
"Jim Niedel MD PhD has worked with the team continuously for over twelve years and will continue to be a senior member of the NLV investment team for NLV-III"Source
HOUSE_OVERSIGHT_024013.jpg
Quote #1
"Performance has been consistently top-quartile since the mid-1990s"Source
HOUSE_OVERSIGHT_024013.jpg
Quote #2
"NLV-I, NLV-II and the healthcare technology portfolios in the Sprout Capital funds have invested over $1.6 billion in healthcare technology companies since 1995."Source
HOUSE_OVERSIGHT_024013.jpg
Quote #3
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document